The new U.S. agreement with Saudi Arabia on civilian nuclear energy has put a fresh spotlight on American companies connected to reactors, fuel, engineering, and long term services. A potential multibillion dollar partnership, stretching over decades, could reshape where capital flows across the energy value chain and who wins the next wave of nuclear build out. At the same time, Congressional approval is still pending, so timing and scale remain uncertain. This article breaks down 3 stocks that are closely exposed to this news, helping you decide which opportunities may deserve a closer look or a place on the watchlist.
Overview: BWX Technologies is a specialist in nuclear components and services, supplying reactors, fuel, and precision parts for U.S. government defense programs, commercial power plants, and medical applications across the nuclear value chain.
Operations: BWX Technologies generates about US$2.4b in revenue from Government Operations and around US$1.0b from Commercial Operations, with most sales coming from the United States and Canada.
Market Cap: US$15.9b
BWX Technologies gives you exposure to both defense nuclear programs and the push for new civilian reactors, so the Saudi nuclear deal shines a bright light on its component manufacturing, fuel, and lifecycle services. The company already has a record backlog supported by multi year Navy propulsion contracts and is expanding into microreactors, advanced fuels like TRISO, and medical isotopes. This broadens higher margin revenue streams. That said, high reliance on government contracts, a premium P/E multiple, and meaningful debt levels mean results are sensitive to shifts in policy, funding, and execution. For investors who want a closer look at how all of this ties into future growth expectations, valuation assumptions, and key contract risks, there is much more beneath the surface here.
BWX Technologies’ mix of defense reactors, advanced fuels, and medical isotopes hints at a bigger story that many investors may be missing, and the 3 key rewards and 1 important warning sign could reveal the one contract risk that changes the whole thesis
Overview: Jacobs Solutions is a global consultant and engineering company that plans, designs, and manages large scale infrastructure, advanced facilities, and long term operations for clients across sectors such as energy, defense, government, transport, and health.
Operations: Jacobs generates about US$11.8b from its Infrastructure & Advanced Facilities segment and around US$1.4b from PA Consulting, with most revenue coming from the United States and Europe.
Market Cap: US$15.3b
Jacobs Solutions sits at the intersection of nuclear energy, infrastructure, and AI heavy data centers, which is why the Saudi civilian nuclear agreement matters. The company already advises on UK small modular reactor projects and runs complex nuclear life cycle work for governments, so any Saudi build out could extend a capability set it is already paid for in the US and Europe. At the same time, earnings growth expectations are described as strong and the stock is trading below one DCF estimate of fair value. Investors still need to weigh issues such as relatively thin net margins, reliance on public sector budgets, and debt not fully covered by operating cash flow. The balance between these potential growth drivers and risks is a key part of the investment story for Jacobs.
Jacobs Solutions sits at the intersection of strong earnings expectations and nuclear infrastructure demand, yet thin margins and debt questions linger. Read the analyst forecasts for Jacobs Solutions to see how this growth story could shift if one assumption breaks.
Overview: Fluor is a global engineering and construction company that designs, builds, and manages complex projects for governments and industries, covering everything from advanced manufacturing and life sciences to mining, energy, and critical infrastructure, including nuclear facilities.
Operations: Fluor generates most of its revenue from Urban Solutions at about US$9.5b, followed by Energy Solutions at roughly US$3.1b and Mission Solutions at around US$2.6b, with a small segment adjustment of US$11m.
Market Cap: US$7.2b
Fluor gives you a front row seat to the Saudi civilian nuclear build out because it already provides EPC services for nuclear power, supports energy transition projects, and has an existing program management agreement with Aramco in the country. At the same time, the company is tied into NuScale’s NRC approved small modular reactor technology and is pursuing nuclear opportunities in Eastern Europe, which could intersect with new Saudi demand for smaller, more flexible reactors. The catch is that margins are currently thin, earnings recently declined sharply, and cash generation has been patchy, so any misstep on large projects or funding could matter. For investors, the key consideration is how these nuclear and Saudi-related developments compare with the execution and balance sheet risks.
Fluor’s thin margins and patchy cash generation could be masking how its nuclear, Saudi, and Eastern European projects fit together, so the analysis report for Fluor might surface the one project risk or upside that flips the story
If BWX Technologies or any of these companies sound like a great opportunity, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value the ideal entry point. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.
Fresh stock ideas can move from quiet, to flying under the radar for now, to fully caught by the crowd. Use these focused picks while it matters and act now.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com